Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Trellus Health PLC ( (GB:TRLS) ) has provided an announcement.
Trellus Health PLC announced it will release its interim results for the period ending 30 June 2025 on 8 September 2025. The company’s focus on chronic gastrointestinal conditions and its innovative platform, Trellus Elevate®, have demonstrated significant reductions in hospitalizations and emergency room visits, highlighting its impact on the healthcare industry and potential for broader application across various chronic conditions.
More about Trellus Health PLC
Trellus Health PLC is a healthcare company specializing in value-based innovative solutions and services aimed at helping individuals with chronic conditions manage their health. The company offers Trellus Elevate®, a digital platform that combines data analytics with personalized resilience programs to address complex chronic conditions, particularly focusing on gastrointestinal issues like Inflammatory Bowel Disease (IBD). Trellus Health’s approach emphasizes the integration of resilience-based methodologies with technology and expert support to improve patient outcomes, reduce hospitalizations, and lower emergency room visits.
Average Trading Volume: 998,484
Technical Sentiment Signal: Sell
Current Market Cap: £1.05M
See more insights into TRLS stock on TipRanks’ Stock Analysis page.